Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 6-K

Aurora Cannabis Inc.

SEC Filing

Filed Sep 24, 2026Accepted Sep 23, 2026, 7:38 PM EDTCIK 1683541Accession 0001279569-26-000915
Share

Company context

Aurora is a global leader in medical cannabis, dedicated to improving lives through scientific expertise, proven performance, and a deep commitment to patient care. Aurora serves medical markets across Canada, Europe, Australia, and New Zealand with a portfolio of trusted, leading brands including Aurora®, MedReleaf®, Pedanios®, IndiMed™, San Raf®, and Whistler Medical Marijuana Corporation®. With world-class GMP-certified manufacturing facilities in Canada and Germany, and a team of industry-leading professionals, Aurora continues to expand its global footprint and deliver consistent, high-quality cannabis products with the purpose of Opening the World to Cannabis™.

Current securities

Recent company filings

  1. 6-K filingSep 16, 2026
  2. SC14D9F/A filingSep 14, 2026
  3. 6-K filingSep 14, 2026
  4. 6-K filingSep 9, 2026
  5. 6-K filingSep 2, 2026

As-filed source

Primary evidence